Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Pierre FabreLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list Pierre Fabre Pharmaceuticals with 1 complete response letter. The most recent is a complete response letter dated Jan 9, 2026: Complete response letter, BL 125745.
Drug approvals, 510(k) clearances, recalls and letters, 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Jan 9, 2026 | Complete response letter, BL 125745Unapproved | Complete response letter |
What this company reported paying US doctors and teaching hospitals each year, $0K of it for research; see every company
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.